Stephen Hoffman has joined Celera Genomics as senior vice president, immunotherapeutics. He will establish and lead a new team to identify disease targets using the company’s genomics and proteomics data.
Hoffman came to Celera from the US Navy, where he directed malaria research efforts. He played a key role in sequencing the genome of Plasmodium falciparum, the microbe responsible for malaria.
Hoffman and his team will initially focus on specific cancers, with the goal of developing vaccines, therapeutics, and small-molecules for treatment and prevention of the disease.
Genomic Solutions has promoted Motonori Akahori to president of its Japanese subsidiary, Genomic Solutions KK. Formerly general manager of the subsidiary, Akahori founded the Japan office of the company’s predecessor, B.I. Systems.
Akahori will serve a major role in identifying global product opportunities for Genomic Solutions.
Clinical bioinformatics company Pioneer has appointed Bernard King as president and CEO. King held a number of positions prior to joining the company, including president and COO of Advanced Bioresearch Associates, president of ChromoXome, and executive vice president for biological sciences and medical affairs at Trega Biosciences.